THC250516P125000
- 0.53
- +0.17+47.22%
Tenet Healthcare Newsroom
Tenet Healthcare Is Maintained at Buy by Truist Securities
Tenet to Participate in BofA Securities 2025 Health Care Conference
Is Tenet Healthcare (NYSE:THC) A Risky Investment?
Goldman Sachs Maintains Tenet Healthcare(THC.US) With Hold Rating, Raises Target Price to $154
Tenet Healthcare Poised to Benefit From Outpatient Growth Due to ASC Leadership, Morgan Stanley Says
Express News | Goldman Sachs Maintains Neutral on Tenet Healthcare, Raises Price Target to $154
Morgan Stanley Raises Price Target on Tenet Healthcare to $175 From $165, Keeps Overweight Rating
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Research Alert: CFRA Maintains Hold View On Shares Of Tenet Healthcare Corporation
Zacks.com Featured Highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont
US MOVERS&SHAKERS Apr 28-May 02, 2025
Tenet Healthcare: Strong Performance and Growth Potential Justify Buy Rating Despite Lowered Price Target
RBC Capital Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $189
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $175
UBS Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $230
Tenet Healthcare Is Maintained at Overweight by Barclays
Tenet Healthcare Price Target Raised to $171.00/Share From $161.00 by Barclays
Tenet Healthcare Q1 Results Exceed Expectations Due to Strong Volume, Cost Control, RBC Says
Tenet Healthcare Is Maintained at Buy by UBS
Tenet Healthcare Price Target Raised to $230.00/Share From $217.00 by UBS